Reckitt Benckiser Group plc (LON:RKT - Get Free Report) has earned a consensus recommendation of "Hold" from the seven analysts that are currently covering the firm, MarketBeat reports. Four investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 12-month target price among brokers that have issued a report on the stock in the last year is GBX 6,279.29.
Several equities analysts have recently issued reports on the company. Citigroup assumed coverage on Reckitt Benckiser Group in a research report on Wednesday, January 14th. They set a "buy" rating and a GBX 7,000 price objective for the company. Royal Bank Of Canada lowered Reckitt Benckiser Group to a "sector perform" rating and reduced their price target for the stock from GBX 6,400 to GBX 6,200 in a research report on Wednesday, January 14th. Jefferies Financial Group increased their price target on Reckitt Benckiser Group from GBX 5,500 to GBX 5,700 and gave the stock a "hold" rating in a research note on Wednesday, January 7th. UBS Group restated a "buy" rating and set a GBX 7,700 price objective on shares of Reckitt Benckiser Group in a research note on Friday, October 17th. Finally, Deutsche Bank Aktiengesellschaft upped their price objective on shares of Reckitt Benckiser Group from GBX 5,600 to GBX 5,700 and gave the stock a "buy" rating in a report on Friday, October 24th.
Read Our Latest Research Report on RKT
Reckitt Benckiser Group Price Performance
LON RKT opened at GBX 6,400 on Monday. Reckitt Benckiser Group has a 52 week low of GBX 4,769.79 and a 52 week high of GBX 6,522.92. The company has a current ratio of 0.69, a quick ratio of 0.46 and a debt-to-equity ratio of 110.26. The stock has a market cap of £41.26 billion, a price-to-earnings ratio of 33.76, a price-to-earnings-growth ratio of 1.10 and a beta of 0.09. The company has a 50-day moving average price of GBX 6,045.09 and a two-hundred day moving average price of GBX 5,821.40.
Reckitt Benckiser Group Company Profile
(
Get Free Report)
At Reckitt, we protect, heal and nurture. We are the company behind some of the world's best known and most trusted Health and Hygiene consumer brands.
Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.
We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.
At Reckitt, we're all making a real difference to people all over the world, every day.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.